After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NYSE and operates within the Biotechnology industry segment. The current market capitalization of Ginkgo Bioworks Holdings Inc is $587.16M. A total of 1.28 million shares were traded on the day, compared to an average of 1.19M shares.
In the most recent transaction, Che Austin bought 99 shares of DNA for 9.53 per share on Dec 31 ’24. In a previous transaction on Dec 30 ’24, Che Austin bought 99 shares at 9.31 per share.
Among the insiders who bought shares, Che Austin acquired of 99 shares on Dec 27 ’24 at a per-share price of $10.24. In another insider transaction, Che Austin bought 99 shares at $9.07 per share on Dec 26 ’24.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, DNA has a high of $68.80 and a low of $5.26.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. DNA’s latest balance sheet shows that the firm has $1.55B in Cash & Short Term Investments as of fiscal 2021. There were $23.03M in debt and $134.76M in liabilities at the time. Its Book Value Per Share was $15.93, while its Total Shareholder’s Equity was $1.57B.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DNA is Buy with a score of 2.17.
